Cytokinetics reported $795.19M in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acadia Pharmaceuticals ACAD:US USD 507.94M 13.62M
Acorda Therapeutics ACOR:US USD 82.12M 10.42M
Amgen AMGN:US USD 22.19B 1.88B
Bayer BAYN:GR EUR 37.76B 652M
Biogen BIIB:US USD 9.79B 25.4M
Brainstorm Cell Therapeutics BCLI:US USD 7.5M 5.3M
Cytokinetics CYTK:US USD 795.19M 89.09M
Eisai 4523:JP JPY 610.12B 24.74B
Exelixis EXEL:US USD 1.62B 222.86M
Geron GERN:US USD 180.25M 41.82M
Halozyme Therapeutics HALO:US USD 739.01M 85.81M
Intra Cellular Therapies ITCI:US USD 737.96M 21.8M
Ligand Pharmaceuticals LGND:US USD 263.6M 43.17M
Novartis NOVN:VX USD 36.91B 44M
Regeneron Pharmaceuticals REGN:US USD 22.06B 6.64B
Roche Holding ROG:VX 33.82B 3.5B